Table 1.
Characteristics of all patients
| Characteristic | T + C (n = 50) | T (n = 67) | p |
|---|---|---|---|
| Age (years) | 0.294 | ||
| Median (range) | 59(36–81) | 61(40–84) | |
| Sex | 0.506 | ||
| Male | 24(48.00%) | 28(38.27%) | |
| Female | 26(52.00%) | 39(61.73%) | |
| Histology | 1.000 | ||
| Adenocarcinoma | 50(100.00%) | 67(100.00%) | |
| ECOG PS | 0.835 | ||
| 0–1 | 49(98.00%) | 66(98.77%) | |
| 2 | 1(2.00%) | 1(1.23%) | |
| Smoking history | 0.986 | ||
| Nerve | 35(70.00%) | 47(72.84%) | |
| Former | 15(30.00%) | 20(27.16%) | |
| EGFR mutation | 0.321 | ||
| Exon 19 deletion | 26(52.00%) | 41(55.56%) | |
| L858R | 21(42.00%) | 23(38.27%) | |
| Others | 3(8.00%) | 3(6.17%) | |
| Brain metastasis | 0.345 | ||
| Yes | 9(18.00%) | 17(23.46%) | |
| No | 41(82.00%) | 50(76.54%) | |
| Stage | 0.713 | ||
| IIIb/IIIc | 3(6.00%) | 3(3.70%) | |
| IV | 47(94.00%) | 64(96.30%) | |
| Cardiovascular | |||
| Hypertension | 15(30.00%) | 21(31.34%) | 0.877 |
| Coronary heart disease | 0(0.00%) | 1(1.23%) | 0.388 |
| Cerebrovascular disease | 0(0.00%) | 2(2.99%) | 0.220 |
| Metabolic | |||
| Diabetes | 6(12.00%) | 6(8.96%) | 0.593 |
| Hyperlipidemia | 2(4.00%) | 1(1.23%) | 0.398 |
| Hyperuricemia | 0(0.00%) | 1(1.23%) | 0.388 |